The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy
The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.